Monday, June 26, 2017
Tags Orix Capital

Tag: Orix Capital

Adverisement

Popular Articles

NewQuest brings in ex-Bain & Co exec amid India office launch

Asian secondaries expert NewQuest Capital Partners has hired former Bain & Company senior principal Sachin Khanderwal amid the launch of its first Indian office.

Oaktree looks to continue homebuilder investment success with Cannon Kirk deal

Oaktree Capital Management has invested in Irish residential homebuilder Cannon Kirk to help it meet debt obligations and grow its business.

EQT overcomes rival PE interest to back €3bn-valued prosthetic limb maker Ottobock

EQT has won the race to buy into German artificial limb business Ottobock in a deal which values the company at more than €3bn.

Carlyle credit opportunities arm hires Popov as new head

Global buyout giant Carlyle has hired Alex Popov as the new head of its credit opportunities business.

PE-newcomer AGIC Capital enters US with second deal from debut fund

Fledgling private equity firm AGIC Capital has made its first move into the US market by leading a consortium to pick up injectable drug container maker Ritedose from Olympus Partners.

Horizon hauls in substantial commitments for $150m-targeting Ukraine fund

Eastern Europe-focused private equity house Horizon Capital has bagged a pair of substantial commitments from for its latest $150m-targeting fundraise.

Idinvest backs pheromone business M2i from €350m-plus targeting Growth Fund II

Pan-European private equity investor Idinvest Partners has tapped its second growth fund to back French pheromones developer M2i.

PE majors miss out on Capita asset management services arm in £888m deal

Private equity firms have missed out on the buyout of outsourcing specialist Capita's asset management services unit after trade buyer Link Group agreed an £888m buyout.

Russian billionaire buys Holland & Barrett from long-held Carlyle business Nature’s Bounty

Russian billionaire Mikhail Fridman's L1 Retail fund has picked up health food and supplies chain Holland & Barrett from Carlyle-backed vitamin and supplements provider Nature's Bounty.

Palatine exits first deal it made using Fund II after ‘extraordinary growth’

UK investment house Palatine Private Equity has exited the first deal it made from its second fund by selling private medical insurance specialist Chase Templeton.